Capital Planning Advisors’s Novartis NVS Stock Holding History

Capital Planning Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,425	Closed	-$428K	–	144
2017 Q1	$428K	Hold	6,425	–	–	0.21%	81
2016 Q4	$419K	Hold	6,425	–	–	0.22%	75
2016 Q3	$455K	Hold	6,425	–	–	0.24%	71
2016 Q2	$475K	Hold	6,425	–	–	0.26%	68
2016 Q1	$417K	Buy	6,425 +223	+4%	+$15.2K	0.2%	72
2015 Q4	$478K	Buy	6,202 +893	+17%	+$70.9K	0.28%	71
2015 Q3	$437K	Hold	5,309	–	–	0.29%	66
2015 Q2	$468K	Hold	5,309	–	–	0.27%	68
2015 Q1	$469K	Hold	5,309	–	–	0.33%	55
2014 Q4	$441K	Buy	+5,309	New	+$440K	0.38%	56

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Capital Planning Advisors's NVS Position: Q2 2017 in Review

Capital Planning Advisors sold out of Novartis (NVS) in Q2 2017, closing a stake of 6,425 shares — an estimated $428K sold.

Capital Planning Advisors first reported a position in NVS in Q4 2014 and held it in 10 quarters. The position peaked at $478K in Q4 2015. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

Capital Planning Advisors reported no remaining Novartis position as of Q2 2017 after selling out during the quarter.
Capital Planning Advisors sold 6,425 Novartis shares in Q2 2017, an estimated $428K.
Capital Planning Advisors first reported a position in Novartis in Q4 2014 and held it in 10 quarters.
Capital Planning Advisors's Novartis position peaked at $478K in Q4 2015.
920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Capital Planning Advisors's 13F filing for Q2 2017, filed 8 Aug 2017.